aluates Reports

$ 0.0

Automative

Global Antihypertensive Agents Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-13H12355

Global Antihypertensive Agents Market Research Report 2022

BUY CHAPTERS

Global Antihypertensive Agents Market Research Report 2024

Code: QYRE-Auto-13H12355

Report

August 2024

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Johnson & Johnson

Sun Pharmaceutical Industries

Merck

Daiichi Sankyo

Takeda

Actelion Ltd

Viatris

United Therapeutics

Lupin Ltd

Hikma Pharmaceuticals

Aurobindo Pharma

Major® Pharmaceuticals

Glenmark Pharmaceuticals

Zydus Pharmaceuticals

Amneal Pharmaceuticals

Endo International

Unichem Laboratories

Huahai Pharmaceutical

Shijiazhuang Pharma Group

Shanghai Shyndec Pharmaceutical

Camber Pharmaceutical

Antihypertensive Agents Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antihypertensive Agents Market

The global Antihypertensive Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Antihypertensive Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihypertensive Agents.

Report Scope

The Antihypertensive Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antihypertensive Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antihypertensive Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antihypertensive Agents Market Report

Report Metric	Details
Report Name	Antihypertensive Agents Market
CAGR	5%
Segment by Type	Thiazide Diuretics Calcium Channel Blockers (CCB) ACE Inhibitors Angiotensin II Receptor Antagonists (ARBs)
Segment by Application	Children Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Baxter International, Pfizer, Sandoz, Teva Pharmaceuticals, Bayer, Johnson & Johnson, Sun Pharmaceutical Industries, Merck, AstraZeneca, Daiichi Sankyo, Takeda, Actelion, Viatris, United Therapeutics, Lupin Limited, Hikma Pharmaceuticals, Aurobindo Pharma, Camber Pharmaceutical, Major Pharmaceuticals, Glenmark Pharmaceuticals, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Unichem Laboratories, Huahai Pharmaceutical, Shijiazhuang Pharma Group, Shanghai Shyndec Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antihypertensive Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antihypertensive Agents Market report?

Ans: The main players in the Antihypertensive Agents Market are Baxter International, Pfizer, Sandoz, Teva Pharmaceuticals, Bayer, Johnson & Johnson, Sun Pharmaceutical Industries, Merck, AstraZeneca, Daiichi Sankyo, Takeda, Actelion, Viatris, United Therapeutics, Lupin Limited, Hikma Pharmaceuticals, Aurobindo Pharma, Camber Pharmaceutical, Major Pharmaceuticals, Glenmark Pharmaceuticals, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Unichem Laboratories, Huahai Pharmaceutical, Shijiazhuang Pharma Group, Shanghai Shyndec Pharmaceutical

What are the Application segmentation covered in the Antihypertensive Agents Market report?

Ans: The Applications covered in the Antihypertensive Agents Market report are Children, Adult

What are the Type segmentation covered in the Antihypertensive Agents Market report?

Ans: The Types covered in the Antihypertensive Agents Market report are Thiazide Diuretics, Calcium Channel Blockers (CCB), ACE Inhibitors, Angiotensin II Receptor Antagonists (ARBs)

Recommended Reports

Cardiovascular Disease Drugs

Hypertension & Related Drug Markets

General Pharmaceutical Agents

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antihypertensive Agents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Thiazide Diuretics

1.2.3 Calcium Channel Blockers (CCB)

1.2.4 ACE Inhibitors

1.2.5 Angiotensin II Receptor Antagonists (ARBs)

1.3 Market by Application

1.3.1 Global Antihypertensive Agents Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Children

1.3.3 Adult

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antihypertensive Agents Market Perspective (2019-2030)

2.2 Antihypertensive Agents Growth Trends by Region

2.2.1 Global Antihypertensive Agents Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Antihypertensive Agents Historic Market Size by Region (2019-2024)

2.2.3 Antihypertensive Agents Forecasted Market Size by Region (2025-2030)

2.3 Antihypertensive Agents Market Dynamics

2.3.1 Antihypertensive Agents Industry Trends

2.3.2 Antihypertensive Agents Market Drivers

2.3.3 Antihypertensive Agents Market Challenges

2.3.4 Antihypertensive Agents Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antihypertensive Agents Players by Revenue

3.1.1 Global Top Antihypertensive Agents Players by Revenue (2019-2024)

3.1.2 Global Antihypertensive Agents Revenue Market Share by Players (2019-2024)

3.2 Global Antihypertensive Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Antihypertensive Agents Revenue

3.4 Global Antihypertensive Agents Market Concentration Ratio

3.4.1 Global Antihypertensive Agents Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antihypertensive Agents Revenue in 2023

3.5 Antihypertensive Agents Key Players Head office and Area Served

3.6 Key Players Antihypertensive Agents Product Solution and Service

3.7 Date of Enter into Antihypertensive Agents Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Antihypertensive Agents Breakdown Data by Type

4.1 Global Antihypertensive Agents Historic Market Size by Type (2019-2024)

4.2 Global Antihypertensive Agents Forecasted Market Size by Type (2025-2030)

5 Antihypertensive Agents Breakdown Data by Application

5.1 Global Antihypertensive Agents Historic Market Size by Application (2019-2024)

5.2 Global Antihypertensive Agents Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Antihypertensive Agents Market Size (2019-2030)

6.2 North America Antihypertensive Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Antihypertensive Agents Market Size by Country (2019-2024)

6.4 North America Antihypertensive Agents Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antihypertensive Agents Market Size (2019-2030)

7.2 Europe Antihypertensive Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Antihypertensive Agents Market Size by Country (2019-2024)

7.4 Europe Antihypertensive Agents Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antihypertensive Agents Market Size (2019-2030)

8.2 Asia-Pacific Antihypertensive Agents Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Antihypertensive Agents Market Size by Region (2019-2024)

8.4 Asia-Pacific Antihypertensive Agents Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antihypertensive Agents Market Size (2019-2030)

9.2 Latin America Antihypertensive Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Antihypertensive Agents Market Size by Country (2019-2024)

9.4 Latin America Antihypertensive Agents Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antihypertensive Agents Market Size (2019-2030)

10.2 Middle East & Africa Antihypertensive Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Antihypertensive Agents Market Size by Country (2019-2024)

10.4 Middle East & Africa Antihypertensive Agents Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Baxter International

11.1.1 Baxter International Company Detail

11.1.2 Baxter International Business Overview

11.1.3 Baxter International Antihypertensive Agents Introduction

11.1.4 Baxter International Revenue in Antihypertensive Agents Business (2019-2024)

11.1.5 Baxter International Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Antihypertensive Agents Introduction

11.2.4 Pfizer Revenue in Antihypertensive Agents Business (2019-2024)

11.2.5 Pfizer Recent Development

11.3 Sandoz

11.3.1 Sandoz Company Detail

11.3.2 Sandoz Business Overview

11.3.3 Sandoz Antihypertensive Agents Introduction

11.3.4 Sandoz Revenue in Antihypertensive Agents Business (2019-2024)

11.3.5 Sandoz Recent Development

11.4 Teva Pharmaceuticals

11.4.1 Teva Pharmaceuticals Company Detail

11.4.2 Teva Pharmaceuticals Business Overview

11.4.3 Teva Pharmaceuticals Antihypertensive Agents Introduction

11.4.4 Teva Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024)

11.4.5 Teva Pharmaceuticals Recent Development

11.5 Bayer

11.5.1 Bayer Company Detail

11.5.2 Bayer Business Overview

11.5.3 Bayer Antihypertensive Agents Introduction

11.5.4 Bayer Revenue in Antihypertensive Agents Business (2019-2024)

11.5.5 Bayer Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Detail

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Antihypertensive Agents Introduction

11.6.4 Johnson & Johnson Revenue in Antihypertensive Agents Business (2019-2024)

11.6.5 Johnson & Johnson Recent Development

11.7 Sun Pharmaceutical Industries

11.7.1 Sun Pharmaceutical Industries Company Detail

11.7.2 Sun Pharmaceutical Industries Business Overview

11.7.3 Sun Pharmaceutical Industries Antihypertensive Agents Introduction

11.7.4 Sun Pharmaceutical Industries Revenue in Antihypertensive Agents Business (2019-2024)

11.7.5 Sun Pharmaceutical Industries Recent Development

11.8 Merck

11.8.1 Merck Company Detail

11.8.2 Merck Business Overview

11.8.3 Merck Antihypertensive Agents Introduction

11.8.4 Merck Revenue in Antihypertensive Agents Business (2019-2024)

11.8.5 Merck Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Detail

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Antihypertensive Agents Introduction

11.9.4 AstraZeneca Revenue in Antihypertensive Agents Business (2019-2024)

11.9.5 AstraZeneca Recent Development

11.10 Daiichi Sankyo

11.10.1 Daiichi Sankyo Company Detail

11.10.2 Daiichi Sankyo Business Overview

11.10.3 Daiichi Sankyo Antihypertensive Agents Introduction

11.10.4 Daiichi Sankyo Revenue in Antihypertensive Agents Business (2019-2024)

11.10.5 Daiichi Sankyo Recent Development

11.11 Takeda

11.11.1 Takeda Company Detail

11.11.2 Takeda Business Overview

11.11.3 Takeda Antihypertensive Agents Introduction

11.11.4 Takeda Revenue in Antihypertensive Agents Business (2019-2024)

11.11.5 Takeda Recent Development

11.12 Actelion

11.12.1 Actelion Company Detail

11.12.2 Actelion Business Overview

11.12.3 Actelion Antihypertensive Agents Introduction

11.12.4 Actelion Revenue in Antihypertensive Agents Business (2019-2024)

11.12.5 Actelion Recent Development

11.13 Viatris

11.13.1 Viatris Company Detail

11.13.2 Viatris Business Overview

11.13.3 Viatris Antihypertensive Agents Introduction

11.13.4 Viatris Revenue in Antihypertensive Agents Business (2019-2024)

11.13.5 Viatris Recent Development

11.14 United Therapeutics

11.14.1 United Therapeutics Company Detail

11.14.2 United Therapeutics Business Overview

11.14.3 United Therapeutics Antihypertensive Agents Introduction

11.14.4 United Therapeutics Revenue in Antihypertensive Agents Business (2019-2024)

11.14.5 United Therapeutics Recent Development

11.15 Lupin Limited

11.15.1 Lupin Limited Company Detail

11.15.2 Lupin Limited Business Overview

11.15.3 Lupin Limited Antihypertensive Agents Introduction

11.15.4 Lupin Limited Revenue in Antihypertensive Agents Business (2019-2024)

11.15.5 Lupin Limited Recent Development

11.16 Hikma Pharmaceuticals

11.16.1 Hikma Pharmaceuticals Company Detail

11.16.2 Hikma Pharmaceuticals Business Overview

11.16.3 Hikma Pharmaceuticals Antihypertensive Agents Introduction

11.16.4 Hikma Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024)

11.16.5 Hikma Pharmaceuticals Recent Development

11.17 Aurobindo Pharma

11.17.1 Aurobindo Pharma Company Detail

11.17.2 Aurobindo Pharma Business Overview

11.17.3 Aurobindo Pharma Antihypertensive Agents Introduction

11.17.4 Aurobindo Pharma Revenue in Antihypertensive Agents Business (2019-2024)

11.17.5 Aurobindo Pharma Recent Development

11.18 Camber Pharmaceutical

11.18.1 Camber Pharmaceutical Company Detail

11.18.2 Camber Pharmaceutical Business Overview

11.18.3 Camber Pharmaceutical Antihypertensive Agents Introduction

11.18.4 Camber Pharmaceutical Revenue in Antihypertensive Agents Business (2019-2024)

11.18.5 Camber Pharmaceutical Recent Development

11.19 Major Pharmaceuticals

11.19.1 Major Pharmaceuticals Company Detail

11.19.2 Major Pharmaceuticals Business Overview

11.19.3 Major Pharmaceuticals Antihypertensive Agents Introduction

11.19.4 Major Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024)

11.19.5 Major Pharmaceuticals Recent Development

11.20 Glenmark Pharmaceuticals

11.20.1 Glenmark Pharmaceuticals Company Detail

11.20.2 Glenmark Pharmaceuticals Business Overview

11.20.3 Glenmark Pharmaceuticals Antihypertensive Agents Introduction

11.20.4 Glenmark Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024)

11.20.5 Glenmark Pharmaceuticals Recent Development

11.21 Zydus Pharmaceuticals

11.21.1 Zydus Pharmaceuticals Company Detail

11.21.2 Zydus Pharmaceuticals Business Overview

11.21.3 Zydus Pharmaceuticals Antihypertensive Agents Introduction

11.21.4 Zydus Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024)

11.21.5 Zydus Pharmaceuticals Recent Development

11.22 Amneal Pharmaceuticals

11.22.1 Amneal Pharmaceuticals Company Detail

11.22.2 Amneal Pharmaceuticals Business Overview

11.22.3 Amneal Pharmaceuticals Antihypertensive Agents Introduction

11.22.4 Amneal Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024)

11.22.5 Amneal Pharmaceuticals Recent Development

11.23 Endo International

11.23.1 Endo International Company Detail

11.23.2 Endo International Business Overview

11.23.3 Endo International Antihypertensive Agents Introduction

11.23.4 Endo International Revenue in Antihypertensive Agents Business (2019-2024)

11.23.5 Endo International Recent Development

11.24 Unichem Laboratories

11.24.1 Unichem Laboratories Company Detail

11.24.2 Unichem Laboratories Business Overview

11.24.3 Unichem Laboratories Antihypertensive Agents Introduction

11.24.4 Unichem Laboratories Revenue in Antihypertensive Agents Business (2019-2024)

11.24.5 Unichem Laboratories Recent Development

11.25 Huahai Pharmaceutical

11.25.1 Huahai Pharmaceutical Company Detail

11.25.2 Huahai Pharmaceutical Business Overview

11.25.3 Huahai Pharmaceutical Antihypertensive Agents Introduction

11.25.4 Huahai Pharmaceutical Revenue in Antihypertensive Agents Business (2019-2024)

11.25.5 Huahai Pharmaceutical Recent Development

11.26 Shijiazhuang Pharma Group

11.26.1 Shijiazhuang Pharma Group Company Detail

11.26.2 Shijiazhuang Pharma Group Business Overview

11.26.3 Shijiazhuang Pharma Group Antihypertensive Agents Introduction

11.26.4 Shijiazhuang Pharma Group Revenue in Antihypertensive Agents Business (2019-2024)

11.26.5 Shijiazhuang Pharma Group Recent Development

11.27 Shanghai Shyndec Pharmaceutical

11.27.1 Shanghai Shyndec Pharmaceutical Company Detail

11.27.2 Shanghai Shyndec Pharmaceutical Business Overview

11.27.3 Shanghai Shyndec Pharmaceutical Antihypertensive Agents Introduction

11.27.4 Shanghai Shyndec Pharmaceutical Revenue in Antihypertensive Agents Business (2019-2024)

11.27.5 Shanghai Shyndec Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bayer

Johnson & Johnson

Sun Pharmaceutical Industries

Merck

Daiichi Sankyo

Takeda

Actelion Ltd

Viatris

United Therapeutics

Lupin Ltd

Hikma Pharmaceuticals

Aurobindo Pharma

Major® Pharmaceuticals

Glenmark Pharmaceuticals

Zydus Pharmaceuticals

Amneal Pharmaceuticals

Endo International

Unichem Laboratories

Huahai Pharmaceutical

Shijiazhuang Pharma Group

Shanghai Shyndec Pharmaceutical

Camber Pharmaceutical

List of Tables

Table 1. Global Antihypertensive Agents Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Thiazide Diuretics

Table 3. Key Players of Calcium Channel Blockers (CCB)

Table 4. Key Players of ACE Inhibitors

Table 5. Key Players of Angiotensin II Receptor Antagonists (ARBs)

Table 6. Global Antihypertensive Agents Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Antihypertensive Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Antihypertensive Agents Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Antihypertensive Agents Market Share by Region (2019-2024)

Table 10. Global Antihypertensive Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Antihypertensive Agents Market Share by Region (2025-2030)

Table 12. Antihypertensive Agents Market Trends

Table 13. Antihypertensive Agents Market Drivers

Table 14. Antihypertensive Agents Market Challenges

Table 15. Antihypertensive Agents Market Restraints

Table 16. Global Antihypertensive Agents Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Antihypertensive Agents Market Share by Players (2019-2024)

Table 18. Global Top Antihypertensive Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihypertensive Agents as of 2023)

Table 19. Ranking of Global Top Antihypertensive Agents Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Antihypertensive Agents Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Antihypertensive Agents Product Solution and Service

Table 23. Date of Enter into Antihypertensive Agents Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Antihypertensive Agents Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Antihypertensive Agents Revenue Market Share by Type (2019-2024)

Table 27. Global Antihypertensive Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Antihypertensive Agents Revenue Market Share by Type (2025-2030)

Table 29. Global Antihypertensive Agents Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Antihypertensive Agents Revenue Market Share by Application (2019-2024)

Table 31. Global Antihypertensive Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Antihypertensive Agents Revenue Market Share by Application (2025-2030)

Table 33. North America Antihypertensive Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Antihypertensive Agents Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Antihypertensive Agents Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Antihypertensive Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Antihypertensive Agents Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Antihypertensive Agents Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Antihypertensive Agents Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Antihypertensive Agents Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Antihypertensive Agents Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Antihypertensive Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Antihypertensive Agents Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antihypertensive Agents Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Antihypertensive Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Antihypertensive Agents Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Antihypertensive Agents Market Size by Country (2025-2030) & (US$ Million)

Table 48. Baxter International Company Detail

Table 49. Baxter International Business Overview

Table 50. Baxter International Antihypertensive Agents Product

Table 51. Baxter International Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 52. Baxter International Recent Development

Table 53. Pfizer Company Detail

Table 54. Pfizer Business Overview

Table 55. Pfizer Antihypertensive Agents Product

Table 56. Pfizer Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 57. Pfizer Recent Development

Table 58. Sandoz Company Detail

Table 59. Sandoz Business Overview

Table 60. Sandoz Antihypertensive Agents Product

Table 61. Sandoz Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 62. Sandoz Recent Development

Table 63. Teva Pharmaceuticals Company Detail

Table 64. Teva Pharmaceuticals Business Overview

Table 65. Teva Pharmaceuticals Antihypertensive Agents Product

Table 66. Teva Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 67. Teva Pharmaceuticals Recent Development

Table 68. Bayer Company Detail

Table 69. Bayer Business Overview

Table 70. Bayer Antihypertensive Agents Product

Table 71. Bayer Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 72. Bayer Recent Development

Table 73. Johnson & Johnson Company Detail

Table 74. Johnson & Johnson Business Overview

Table 75. Johnson & Johnson Antihypertensive Agents Product

Table 76. Johnson & Johnson Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 77. Johnson & Johnson Recent Development

Table 78. Sun Pharmaceutical Industries Company Detail

Table 79. Sun Pharmaceutical Industries Business Overview

Table 80. Sun Pharmaceutical Industries Antihypertensive Agents Product

Table 81. Sun Pharmaceutical Industries Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 82. Sun Pharmaceutical Industries Recent Development

Table 83. Merck Company Detail

Table 84. Merck Business Overview

Table 85. Merck Antihypertensive Agents Product

Table 86. Merck Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 87. Merck Recent Development

Table 88. AstraZeneca Company Detail

Table 89. AstraZeneca Business Overview

Table 90. AstraZeneca Antihypertensive Agents Product

Table 91. AstraZeneca Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 92. AstraZeneca Recent Development

Table 93. Daiichi Sankyo Company Detail

Table 94. Daiichi Sankyo Business Overview

Table 95. Daiichi Sankyo Antihypertensive Agents Product

Table 96. Daiichi Sankyo Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 97. Daiichi Sankyo Recent Development

Table 98. Takeda Company Detail

Table 99. Takeda Business Overview

Table 100. Takeda Antihypertensive Agents Product

Table 101. Takeda Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 102. Takeda Recent Development

Table 103. Actelion Company Detail

Table 104. Actelion Business Overview

Table 105. Actelion Antihypertensive Agents Product

Table 106. Actelion Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 107. Actelion Recent Development

Table 108. Viatris Company Detail

Table 109. Viatris Business Overview

Table 110. Viatris Antihypertensive Agents Product

Table 111. Viatris Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 112. Viatris Recent Development

Table 113. United Therapeutics Company Detail

Table 114. United Therapeutics Business Overview

Table 115. United Therapeutics Antihypertensive Agents Product

Table 116. United Therapeutics Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 117. United Therapeutics Recent Development

Table 118. Lupin Limited Company Detail

Table 119. Lupin Limited Business Overview

Table 120. Lupin Limited Antihypertensive Agents Product

Table 121. Lupin Limited Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 122. Lupin Limited Recent Development

Table 123. Hikma Pharmaceuticals Company Detail

Table 124. Hikma Pharmaceuticals Business Overview

Table 125. Hikma Pharmaceuticals Antihypertensive Agents Product

Table 126. Hikma Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 127. Hikma Pharmaceuticals Recent Development

Table 128. Aurobindo Pharma Company Detail

Table 129. Aurobindo Pharma Business Overview

Table 130. Aurobindo Pharma Antihypertensive Agents Product

Table 131. Aurobindo Pharma Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 132. Aurobindo Pharma Recent Development

Table 133. Camber Pharmaceutical Company Detail

Table 134. Camber Pharmaceutical Business Overview

Table 135. Camber Pharmaceutical Antihypertensive Agents Product

Table 136. Camber Pharmaceutical Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 137. Camber Pharmaceutical Recent Development

Table 138. Major Pharmaceuticals Company Detail

Table 139. Major Pharmaceuticals Business Overview

Table 140. Major Pharmaceuticals Antihypertensive Agents Product

Table 141. Major Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 142. Major Pharmaceuticals Recent Development

Table 143. Glenmark Pharmaceuticals Company Detail

Table 144. Glenmark Pharmaceuticals Business Overview

Table 145. Glenmark Pharmaceuticals Antihypertensive Agents Product

Table 146. Glenmark Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 147. Glenmark Pharmaceuticals Recent Development

Table 148. Zydus Pharmaceuticals Company Detail

Table 149. Zydus Pharmaceuticals Business Overview

Table 150. Zydus Pharmaceuticals Antihypertensive Agents Product

Table 151. Zydus Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 152. Zydus Pharmaceuticals Recent Development

Table 153. Amneal Pharmaceuticals Company Detail

Table 154. Amneal Pharmaceuticals Business Overview

Table 155. Amneal Pharmaceuticals Antihypertensive Agents Product

Table 156. Amneal Pharmaceuticals Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 157. Amneal Pharmaceuticals Recent Development

Table 158. Endo International Company Detail

Table 159. Endo International Business Overview

Table 160. Endo International Antihypertensive Agents Product

Table 161. Endo International Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 162. Endo International Recent Development

Table 163. Unichem Laboratories Company Detail

Table 164. Unichem Laboratories Business Overview

Table 165. Unichem Laboratories Antihypertensive Agents Product

Table 166. Unichem Laboratories Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 167. Unichem Laboratories Recent Development

Table 168. Huahai Pharmaceutical Company Detail

Table 169. Huahai Pharmaceutical Business Overview

Table 170. Huahai Pharmaceutical Antihypertensive Agents Product

Table 171. Huahai Pharmaceutical Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 172. Huahai Pharmaceutical Recent Development

Table 173. Shijiazhuang Pharma Group Company Detail

Table 174. Shijiazhuang Pharma Group Business Overview

Table 175. Shijiazhuang Pharma Group Antihypertensive Agents Product

Table 176. Shijiazhuang Pharma Group Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 177. Shijiazhuang Pharma Group Recent Development

Table 178. Shanghai Shyndec Pharmaceutical Company Detail

Table 179. Shanghai Shyndec Pharmaceutical Business Overview

Table 180. Shanghai Shyndec Pharmaceutical Antihypertensive Agents Product

Table 181. Shanghai Shyndec Pharmaceutical Revenue in Antihypertensive Agents Business (2019-2024) & (US$ Million)

Table 182. Shanghai Shyndec Pharmaceutical Recent Development

Table 183. Research Programs/Design for This Report

Table 184. Key Data Information from Secondary Sources

Table 185. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antihypertensive Agents Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Antihypertensive Agents Market Share by Type: 2023 VS 2030

Figure 3. Thiazide Diuretics Features

Figure 4. Calcium Channel Blockers (CCB) Features

Figure 5. ACE Inhibitors Features

Figure 6. Angiotensin II Receptor Antagonists (ARBs) Features

Figure 7. Global Antihypertensive Agents Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Antihypertensive Agents Market Share by Application: 2023 VS 2030

Figure 9. Children Case Studies

Figure 10. Adult Case Studies

Figure 11. Antihypertensive Agents Report Years Considered

Figure 12. Global Antihypertensive Agents Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Antihypertensive Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Antihypertensive Agents Market Share by Region: 2023 VS 2030

Figure 15. Global Antihypertensive Agents Market Share by Players in 2023

Figure 16. Global Top Antihypertensive Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihypertensive Agents as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Antihypertensive Agents Revenue in 2023

Figure 18. North America Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Antihypertensive Agents Market Share by Country (2019-2030)

Figure 20. United States Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Antihypertensive Agents Market Share by Country (2019-2030)

Figure 24. Germany Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Antihypertensive Agents Market Share by Region (2019-2030)

Figure 32. China Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Antihypertensive Agents Market Share by Country (2019-2030)

Figure 40. Mexico Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Antihypertensive Agents Market Share by Country (2019-2030)

Figure 44. Turkey Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Antihypertensive Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Baxter International Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 47. Pfizer Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 48. Sandoz Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 50. Bayer Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 51. Johnson & Johnson Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 52. Sun Pharmaceutical Industries Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 53. Merck Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 54. AstraZeneca Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 55. Daiichi Sankyo Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 56. Takeda Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 57. Actelion Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 58. Viatris Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 59. United Therapeutics Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 60. Lupin Limited Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 61. Hikma Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 62. Aurobindo Pharma Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 63. Camber Pharmaceutical Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 64. Major Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 65. Glenmark Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 66. Zydus Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 67. Amneal Pharmaceuticals Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 68. Endo International Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 69. Unichem Laboratories Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 70. Huahai Pharmaceutical Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 71. Shijiazhuang Pharma Group Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 72. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Antihypertensive Agents Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Hypertensive Heart Disease Drug Market Research Report 2025

Hypertension and Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diuretics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diuretic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cholesterol Lowering Drugs Market Research Report 2024

Cardiac Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pulmonary Hypertension Drug Market Research Report 2025

Global Cardiovascular Disease Nursing Drugs Market Research Report 2025

Cholesterol Reducer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Cardiovascular Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antidepressant Medication Market Research Report 2025

Global Chronic Kidney Disease Drugs Market Research Report 2025

Global Pre Eclampsia Treatment Market Research Report 2025

Global Mild Moderate Primary Hypertension Drugs Market Research Report 2025

Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Weekly Pill Organizer Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-19A18322

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E3525

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35T3049

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33Y1801

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Antihypertensive Agents Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-13H12355

Global Antihypertensive Agents Market Research Report 2024

FEATURED COMPANIES

Antihypertensive Agents Market Size

Antihypertensive Agents Market

Report Scope

Scope of Antihypertensive Agents Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Antihypertensive Agents Market report?

What are the Application segmentation covered in the Antihypertensive Agents Market report?

What are the Type segmentation covered in the Antihypertensive Agents Market report?

Recommended Reports

Cardiovascular Disease Drugs

Hypertension & Related Drug Markets

General Pharmaceutical Agents

FEATURED COMPANIES

RELATED REPORTS